Montefiore Health System: NIH Delivers $4.3 Million to Support Convalescent Plasma Clinical Trial
August 19, 2020
August 19, 2020
BRONX, New York, Aug. 19 -- Montefiore Health System issued the following news release:
As the search for COVID-19 therapies continues, convalescent plasma--distilled from the blood of people who have recovered from COVID-19--has emerged as a promising treatment option. Now, the National Institutes of Health has awarded Albert Einstein College of Medicine and Montefiore a $4.3 million grant to support a randomized, double-blind, placebo-controlled phase 2 clinical trial that launche . . .
As the search for COVID-19 therapies continues, convalescent plasma--distilled from the blood of people who have recovered from COVID-19--has emerged as a promising treatment option. Now, the National Institutes of Health has awarded Albert Einstein College of Medicine and Montefiore a $4.3 million grant to support a randomized, double-blind, placebo-controlled phase 2 clinical trial that launche . . .